Company Name: Omeros Corporation    

Omeros Corporation is a biopharmaceutical company. The company is engaged in the development and commercialization of small-molecule and protein therapeutics.  Areas of focus include:

  • Inflammation
  • Coagulopathies
  • Central nervous system disorders

The company markets OMIDRIA for use during cataract surgery and intraocular lens replacement.

Ticker Symbol: OMER (NASDAQ)

Company Website:

Social Media: Omeros Corporation LinkedIn

Headquarters: Seattle, WA